AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) did something many other stocks didn't last year. After all, these stocks offer a track record of earnings growth and dividend increases. The company's mega-blockbuster immunology drug, Humira, recently started facing competition in the U.S. And AbbVie predicts that this will result in a 37% decline in the drug's sales this year.
Tesla's loss of $328.3 billion this year in stock value certainly hurts. But it's only the second-largest market value loss in the S&P 500.
On paper, Mark Zuckerberg is Meta’s lowest-paid employee, with a $1 dollar salary and no bonus.
This growth ETF has nicely outperformed the S&P 500 since its inception.
American Airlines and Southwest Airlines both lost money in the first quarter, and Southwest said Thursday that it will limit hiring and close operations at four airports. Airlines are dealing with higher labor costs and delays in getting new planes from Boeing, which is limiting their ability to add more flights at a time of high demand for travel. American said it lost $312 million as labor costs rose 18%, or nearly $600 million.
You'll only find seven different stocks in this billionaire's portfolio, and only one of them is a "big tech" company.
One of Capitol Hill's most-active stock traders is sending a company with well-defined competitive advantages -- that also happens to be on the verge of its first-ever stock split -- to the chopping block.
With rising inflation, American consumers are increasingly turning to the Chinese e-commerce platform Temu for their shopping needs. With its enticing tagline “Shop like a billionaire,” Temu has captured 17% of the U.S. market share, posing a challenge to traditional American retailers such as Amazon.com Inc., Dollar Tree Inc. and Five Below Inc. The rise highlights the lucrative and disruptive nature of startups. Owned and operated by PDD Holdings Inc. (NASDAQ:PDD), Temu offers a wide range of
Bitcoin block subsidies were recently reduced by half for the fourth time in history, and halving events have always led to significant price appreciation.
These stocks all deserve to be trading at far higher prices, and it may not be too long before they start to rally.
This stock is reasonably priced, even after explosive gains.